Skip to main content
ZIM Laboratories Limited logo

ZIM Laboratories Limited — Investor Relations & Filings

Ticker · ZIMLAB ISIN · INE518E01015 LEI · 335800YPYG1O3ML66R52 BSE.NS Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2025-08-07 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS ZIMLAB

About ZIM Laboratories Limited

https://www.zimlab.in/

ZIM Laboratories Limited is a research-driven organization specializing in the development and manufacturing of innovative drug delivery solutions. The company focuses on enhancing the efficacy and patient compliance of generic medicines through advanced formulation technologies. Its core product portfolio includes Oral Disintegrating Films (ODF), Oral Disintegrating Tablets (ODT), pellets, and taste-masked granules. Utilizing proprietary technology platforms like Thinoral, the company provides differentiated products across various therapeutic segments, including central nervous system, cardiovascular, and gastrointestinal health. ZIM Laboratories offers end-to-end services from product development and clinical trials to commercial manufacturing. The organization serves a global clientele, providing value-added generic formulations that address specific patient needs such as ease of administration and rapid onset of action.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is an official communication from the company to stock exchanges regarding the outcome of a Board Meeting held on August 7, 2025. It includes approval of unaudited financial results for the quarter ended June 30, 2025, both standalone and consolidated, along with a limited review report by the statutory auditors. The document contains detailed financial data for the quarter, notes on accounting standards, and auditor's review reports. The presence of unaudited quarterly financial results and auditor's limited review indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, contains substantive financial data and analysis, and is not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2025-08-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding the schedule of an Investors/Analysts Meet. It references compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, which pertains to disclosure obligations. The document does not contain any financial data, report content, or detailed analysis. It is essentially an announcement of a meeting schedule, not a report or transcript. The length is only 2149 characters, which is quite short and fits the pattern of a regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-06 English
Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the grant of Marketing Authorization for a pharmaceutical product by the Therapeutic Goods Administration (TGA) in Australia. It is addressed to stock exchanges and signed by the company secretary. The content focuses on the marketing authorization event and its strategic importance, without containing any financial statements, detailed financial data, or regulatory filings. The document length is 4079 characters, which is relatively short and typical for a press release. It does not present financial results, management discussion, or regulatory compliance details. Therefore, it is best classified as a Capital/Financing Update (CAP) because it relates to a significant business development impacting the company's market and product portfolio, which is typical for CAP filings. It is not an announcement of a report publication, nor a regulatory filing or earnings release.
2025-08-04 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) regarding the outcome of an EU GMP inspection at the company's manufacturing facility. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, which pertains to disclosure obligations. The content details the inspection results, non-compliance issues, and the company's commitment to corrective actions. The document is short (3003 characters) and serves as an announcement of an event (inspection outcome) rather than a detailed report or financial statement. It does not contain financial data, management discussion, or audit information. It is not a report publication announcement since it does not mention any report being attached or published. The nature of the document fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-08-01 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a notice published in newspapers regarding a Special Window for Re-Lodgement of Transfer Requests of Physical Shares. It is addressed to stock exchanges and references compliance with SEBI regulations. The content is an announcement informing shareholders about the opening of a special window for share transfer requests. There is no financial data, no report attached or referenced as being published, and no detailed financial or management information. The document is essentially a regulatory announcement related to shareholder procedures and compliance. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is not a voting result or a capital change announcement. Given the nature of the document as a regulatory compliance notice and announcement, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-07-28 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a notice submitted to stock exchanges regarding the publication of a newspaper notice about the transfer of equity shares to the Investor Education and Protection Fund (IEPF) Account. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations and the Companies Act, 2013. The content is primarily an announcement of a notice published in newspapers, not the notice itself or a detailed report. The document length is about 15,000 characters, but the core content is an announcement of the notice publication, not a full report or financial data. Therefore, this fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain financial statements or detailed report data.
2025-07-22 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.